A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ManagementF. Xavier Pi‐Sunyer, John Wilding, David C.W. Lau et al.|New England Journal of Medicine|2015Cited by 2.6k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, Arne Astrup et al.|The Lancet|2017Cited by 843
Identification and functional analysis of novel human melanocortin-4 receptor variants.Wei Gu, David B. Allison, Zhiguang Tu et al.|Diabetes|1999Cited by 193